Antiviral peptides against the main protease of SARS-CoV-2: A molecular docking and dynamics study
- PMID: 34909064
- PMCID: PMC8277949
- DOI: 10.1016/j.arabjc.2021.103315
Antiviral peptides against the main protease of SARS-CoV-2: A molecular docking and dynamics study
Abstract
The recent coronavirus outbreak has changed the world's economy and health sectors due to the high mortality and transmission rates. Because the development of new effective vaccines or treatments against the virus can take time, an urgent need exists for the rapid development and design of new drug candidates to combat this pathogen. Here, we obtained antiviral peptides obtained from the data repository of antimicrobial peptides (DRAMP) and screened their predicted tertiary structures for the ability to inhibit the main protease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using multiple combinatorial docking programs, including PatchDock, FireDock, and ClusPro. The four best peptides, DRAMP00877, DRAMP02333, DRAMP02669, and DRAMP03804, had binding energies of -1125.3, -1084.5, -1005.2, and -924.2 Kcal/mol, respectively, as determined using ClusPro, and binding energies of -55.37, -50.96, -49.25, -54.81 Kcal/mol, respectively, as determined using FireDock, which were better binding energy values than observed for other peptide molecules. These peptides were found to bind with the active cavity of the SARS-CoV-2 main protease; at Glu166, Cys145, Asn142, Phe140, and Met165, in addition to the substrate-binding sites, Domain 2 and Domain 3, whereas fewer interactions were observed with Domain 1. The docking studies were further confirmed by a molecular dynamics simulation study, in which several descriptors, including the root-mean-square difference (RMSD), root-mean-square fluctuation (RMSF), solvent-accessible surface area (SASA), radius of gyration (Rg), and hydrogen bond formation, confirmed the stable nature of the peptide-main protease complexes. Toxicity and allergenicity studies confirmed the non-allergenic nature of the peptides. This present study suggests that these identified antiviral peptide molecules might inhibit the main protease of SARS-CoV-2, although further wet-lab experiments remain necessary to verify these findings.
Keywords: Lead identification; Molecular dynamics; Peptide; Peptide–protein docking; SARS-CoV-2.
© 2021 The Author(s).
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
![Fig. 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8277949/bin/gr1_lrg.gif)
![Fig. 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8277949/bin/gr2_lrg.gif)
![Fig. 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8277949/bin/gr3_lrg.gif)
![Fig. 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8277949/bin/gr4_lrg.gif)
![Fig. 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8277949/bin/gr5_lrg.gif)
Similar articles
-
Identification of medicinal plant-based phytochemicals as a potential inhibitor for SARS-CoV-2 main protease (Mpro) using molecular docking and deep learning methods.Comput Biol Med. 2023 May;157:106785. doi: 10.1016/j.compbiomed.2023.106785. Epub 2023 Mar 11. Comput Biol Med. 2023. PMID: 36931201 Free PMC article.
-
Plant-derived compounds effectively inhibit the main protease of SARS-CoV-2: An in silico approach.PLoS One. 2022 Aug 23;17(8):e0273341. doi: 10.1371/journal.pone.0273341. eCollection 2022. PLoS One. 2022. PMID: 35998194 Free PMC article.
-
Molecular Docking and Dynamics Studies to Explore Effective Inhibitory Peptides Against the Spike Receptor Binding Domain of SARS-CoV-2.Front Mol Biosci. 2022 Jan 27;8:791642. doi: 10.3389/fmolb.2021.791642. eCollection 2021. Front Mol Biosci. 2022. PMID: 35187069 Free PMC article.
-
Potential Role of Colchicine in Combating COVID-19 Cytokine Storm and Its Ability to Inhibit Protease Enzyme of SARS-CoV-2 as Conferred by Molecular Docking Analysis.Medicina (Kaunas). 2021 Dec 23;58(1):20. doi: 10.3390/medicina58010020. Medicina (Kaunas). 2021. PMID: 35056328 Free PMC article. Review.
-
Molecular docking and dynamics study to explore phytochemical ligand molecules against the main protease of SARS-CoV-2 from extensive phytochemical datasets.Expert Rev Clin Pharmacol. 2021 Oct;14(10):1305-1315. doi: 10.1080/17512433.2021.1959318. Epub 2021 Aug 5. Expert Rev Clin Pharmacol. 2021. PMID: 34301158
Cited by
-
Evaluating the Metabolomic Profile and Anti-Pathogenic Properties of Cannabis Species.Metabolites. 2024 Apr 26;14(5):253. doi: 10.3390/metabo14050253. Metabolites. 2024. PMID: 38786730 Free PMC article. Review.
-
Recent advances in the exploration and discovery of SARS-CoV-2 inhibitory peptides from edible animal proteins.Front Nutr. 2024 Feb 7;11:1346510. doi: 10.3389/fnut.2024.1346510. eCollection 2024. Front Nutr. 2024. PMID: 38389797 Free PMC article. Review.
-
An in silico approach to develop potential therapies against Middle East Respiratory Syndrome Coronavirus (MERS-CoV).Heliyon. 2024 Feb 9;10(4):e25837. doi: 10.1016/j.heliyon.2024.e25837. eCollection 2024 Feb 29. Heliyon. 2024. PMID: 38379969 Free PMC article.
-
Effects of gamma-radiation on microbial, nutritional, and functional properties of Katimon mango peels: A combined biochemical and in silico studies.Heliyon. 2023 Oct 31;9(11):e21556. doi: 10.1016/j.heliyon.2023.e21556. eCollection 2023 Nov. Heliyon. 2023. PMID: 38027912 Free PMC article.
-
A computational simulation appraisal of banana lectin as a potential anti-SARS-CoV-2 candidate by targeting the receptor-binding domain.J Genet Eng Biotechnol. 2023 Nov 28;21(1):148. doi: 10.1186/s43141-023-00569-8. J Genet Eng Biotechnol. 2023. PMID: 38015308 Free PMC article.
References
-
- Al-Karmalawy A.A., Alnajjar R., Dahab M., Metwaly A., Eissa I. Molecular docking and dynamics simulations reveal the potential of anti-HCV drugs to inhibit COVID-19 main protease. Pharm Sci. 2021 doi: 10.34172/PS.2021.3. - DOI
LinkOut - more resources
Full Text Sources
Miscellaneous